Public notice: Guideline Development Group Meeting on Targeted Next-Generation Sequencing for Detection of TB Drug Resistance
18 April 2023
| Publication

Overview
The World Health Organization (WHO) Global TB Programme (GTB)
would like to announce an upcoming Guideline Development Group meeting on
the use of targeted Next-Generation Sequencing (tNGS) for detection of TB drug
resistance, to be held 2-5 May 2023 in the WHO headquarters in Geneva,
Switzerland. The objectives of the meeting are to assess the
available evidence on the accuracy, the impact on patient-important outcomes,
the costs and cost-effectiveness, and the feasibility, acceptability, and
potential impact on equity of tNGS solutions for diagnosis of DR-TB; and to
issue global recommendations and guidance on the clinical and programmatic use
of tNGS solutions for detection of TB drug resistance.
WHO Team
Global Programme on Tuberculosis and Lung Health (GTB)